Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein

抗体 τ蛋白 α-突触核蛋白 路易体 帕金森病 路易氏体型失智症 补体C1q 免疫疗法 神经炎症 补体系统 双特异性抗体 化学 神经科学 痴呆 免疫学 阿尔茨海默病 生物 疾病 医学 病理 炎症 单克隆抗体 免疫系统
作者
Wim Hendricus Quint,Irena Matečko‐Burmann,Irene Schilcher,Tina Löffler,Michael Schöll,Björn M. Burmann,Thomas Vogels
出处
期刊:Journal of Alzheimer's Disease [IOS Press]
卷期号:80 (2): 813-829 被引量:7
标识
DOI:10.3233/jad-201334
摘要

BACKGROUND: Alzheimer's disease (AD) and other tauopathies are neurodegenerative disorders characterized by cellular accumulation of aggregated tau protein. Tau pathology within these disorders is accompanied by chronic neuroinflammation, such as activation of the classical complement pathway by complement initiation factor C1q. Additionally, about half of the AD cases present with inclusions composed of aggregated alpha-synuclein called Lewy bodies. Lewy bodies in disorders such as Parkinson's disease and Lewy body dementia also frequently occur together with tau pathology. OBJECTIVE: Immunotherapy is currently the most promising treatment strategy for tauopathies. However, the presence of multiple pathological processes within tauopathies makes it desirable to simultaneously target more than one disease pathway. METHODS: Herein, we have developed three bispecific antibodies based on published antibody binding region sequences. One bispecific antibody binds to tau plus alpha-synuclein and two bispecific antibodies bind to tau plus C1q. RESULTS: Affinity of the bispecific antibodies to their targets compared to their monospecific counterparts ranged from nearly identical to one order of magnitude lower. All bispecific antibodies retained binding to aggregated protein in patient-derived brain sections. The bispecific antibodies also retained their ability to inhibit aggregation of recombinant tau, regardless of whether the tau binding sites were in IgG or scFv format. Mono- and bispecific antibodies inhibited cellular seeding induced by AD-derived pathological tau with similar efficacy. Finally, both Tau-C1q bispecific antibodies completely inhibited the classical complement pathway. CONCLUSION: Bispecific antibodies that bind to multiple pathological targets may therefore present a promising approach to treat tauopathies and other neurodegenerative disorders.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
铱铂完成签到,获得积分10
3秒前
英姑的应助被酸酸采纳,获得10
3秒前
Sochan完成签到,获得积分10
3秒前
禹hs发布了新的文献求助10
3秒前
DW的应助被陈婕采纳,获得10
3秒前
4秒前
辛勤的绮兰完成签到,获得积分10
5秒前
5秒前
鱼鱼完成签到,获得积分10
6秒前
6秒前
在水一方的应助被675675采纳,获得10
8秒前
幸福台灯完成签到,获得积分10
8秒前
Captainhana完成签到,获得积分10
10秒前
11秒前
嘤嘤嘤发布了新的文献求助10
12秒前
三千白发生完成签到,获得积分10
12秒前
纳古菌完成签到,获得积分10
13秒前
SG完成签到,获得积分10
13秒前
听话的无极完成签到,获得积分10
13秒前
13秒前
123456完成签到,获得积分10
14秒前
努力小人完成签到,获得积分10
14秒前
15秒前
liang完成签到,获得积分10
15秒前
15秒前
青葙完成签到,获得积分10
16秒前
123456发布了新的文献求助10
17秒前
11NING发布了新的文献求助10
18秒前
Ysk完成签到,获得积分10
18秒前
20秒前
675675发布了新的文献求助10
22秒前
汉堡包的应助被小艾同学采纳,获得10
22秒前
23秒前
26秒前
11NING完成签到,获得积分10
26秒前
26秒前
SCI完成签到,获得积分10
27秒前
Koi发布了新的文献求助10
27秒前
禹hs完成签到,获得积分10
30秒前
吱ing完成签到 ,获得积分10
31秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568